Xiaohong Ma
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 14, 2025
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis.Rui Sun, Ying Zhao, Yao Liu
|Jan 24, 2023
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma.Lina Wei, Xiaohong Ma, Yixin Hou
|Dec 22, 2022
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL.Xiaohong Ma, Min Xia, Lina Wei
|May 27, 2021
Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma.Xiaohong Ma, Tianyi Zhao, Hong Yan
|Jun 20, 2019
DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma.Qing Zhou, Wenzhi Li, Deshui Kong
Pageof 1
